nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—Olsalazine—Sulfasalazine—ankylosing spondylitis	0.342	1	CrCrCtD
Diflunisal—osteoarthritis—Prednisone—ankylosing spondylitis	0.204	0.5	CpDpCtD
Diflunisal—osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.204	0.5	CpDpCtD
Diflunisal—PTGS2—Triamcinolone—ankylosing spondylitis	0.0438	0.19	CbGbCtD
Diflunisal—PTGS2—Sulfasalazine—ankylosing spondylitis	0.0438	0.19	CbGbCtD
Diflunisal—PTGS2—Betamethasone—ankylosing spondylitis	0.0376	0.163	CbGbCtD
Diflunisal—PTGS1—Sulfasalazine—ankylosing spondylitis	0.037	0.161	CbGbCtD
Diflunisal—ALB—Prednisone—ankylosing spondylitis	0.0221	0.0959	CbGbCtD
Diflunisal—PTGS2—Dexamethasone—ankylosing spondylitis	0.0219	0.095	CbGbCtD
Diflunisal—SLC22A6—Methotrexate—ankylosing spondylitis	0.013	0.0565	CbGbCtD
Diflunisal—ALB—Methotrexate—ankylosing spondylitis	0.0111	0.0481	CbGbCtD
Diflunisal—TTR—vertebral column—ankylosing spondylitis	0.00146	0.462	CbGeAlD
Diflunisal—PTGS2—skeletal joint—ankylosing spondylitis	0.000637	0.202	CbGeAlD
Diflunisal—PTGS2—synovial membrane of synovial joint—ankylosing spondylitis	0.000484	0.153	CbGeAlD
Diflunisal—PTGS2—cartilage tissue—ankylosing spondylitis	0.000428	0.136	CbGeAlD
Diflunisal—Allergic cutaneous angiitis—Methotrexate—ankylosing spondylitis	0.000382	0.0268	CcSEcCtD
Diflunisal—PTGS2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.000327	0.159	CbGdCrCtD
Diflunisal—PTGS2—Fluocinonide—Dexamethasone—ankylosing spondylitis	0.000321	0.156	CbGdCrCtD
Diflunisal—PTGS2—Fluocinonide—Betamethasone—ankylosing spondylitis	0.000321	0.156	CbGdCrCtD
Diflunisal—PTGS2—Fluocinonide—Triamcinolone—ankylosing spondylitis	0.000314	0.153	CbGdCrCtD
Diflunisal—Peptic ulcer—Prednisolone—ankylosing spondylitis	0.000299	0.021	CcSEcCtD
Diflunisal—Peptic ulcer—Triamcinolone—ankylosing spondylitis	0.000275	0.0193	CcSEcCtD
Diflunisal—Peptic ulcer—Methylprednisolone—ankylosing spondylitis	0.000274	0.0193	CcSEcCtD
Diflunisal—Peptic ulcer—Betamethasone—ankylosing spondylitis	0.000249	0.0175	CcSEcCtD
Diflunisal—Peptic ulcer—Dexamethasone—ankylosing spondylitis	0.000249	0.0175	CcSEcCtD
Diflunisal—Leukocytoclastic vasculitis—Methotrexate—ankylosing spondylitis	0.000247	0.0174	CcSEcCtD
Diflunisal—Peptic ulcer—Prednisone—ankylosing spondylitis	0.000217	0.0153	CcSEcCtD
Diflunisal—PTGS2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000197	0.0957	CbGdCrCtD
Diflunisal—PTGS2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000194	0.0942	CbGdCrCtD
Diflunisal—PTGS2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000194	0.0942	CbGdCrCtD
Diflunisal—PTGS2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.00019	0.0921	CbGdCrCtD
Diflunisal—Visual disturbance—Prednisolone—ankylosing spondylitis	0.000153	0.0108	CcSEcCtD
Diflunisal—Proteinuria—Methotrexate—ankylosing spondylitis	0.000138	0.0097	CcSEcCtD
Diflunisal—Protein urine present—Methotrexate—ankylosing spondylitis	0.000136	0.00957	CcSEcCtD
Diflunisal—Visual disturbance—Betamethasone—ankylosing spondylitis	0.000128	0.00897	CcSEcCtD
Diflunisal—Visual disturbance—Dexamethasone—ankylosing spondylitis	0.000128	0.00897	CcSEcCtD
Diflunisal—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.000113	0.00795	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Prednisone—ankylosing spondylitis	0.000105	0.0074	CcSEcCtD
Diflunisal—Photosensitivity—Methotrexate—ankylosing spondylitis	0.0001	0.00705	CcSEcCtD
Diflunisal—Sweating—Methylprednisolone—ankylosing spondylitis	9.83e-05	0.00691	CcSEcCtD
Diflunisal—Visual impairment—Prednisolone—ankylosing spondylitis	9.67e-05	0.00679	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	9.34e-05	0.00656	CcSEcCtD
Diflunisal—Visual disturbance—Methotrexate—ankylosing spondylitis	9.3e-05	0.00653	CcSEcCtD
Diflunisal—Hallucination—Methylprednisolone—ankylosing spondylitis	9.16e-05	0.00644	CcSEcCtD
Diflunisal—Visual impairment—Methylprednisolone—ankylosing spondylitis	8.87e-05	0.00623	CcSEcCtD
Diflunisal—Hallucination—Betamethasone—ankylosing spondylitis	8.33e-05	0.00585	CcSEcCtD
Diflunisal—Hallucination—Dexamethasone—ankylosing spondylitis	8.33e-05	0.00585	CcSEcCtD
Diflunisal—Vision blurred—Prednisolone—ankylosing spondylitis	8.23e-05	0.00578	CcSEcCtD
Diflunisal—Visual impairment—Betamethasone—ankylosing spondylitis	8.07e-05	0.00567	CcSEcCtD
Diflunisal—Visual impairment—Dexamethasone—ankylosing spondylitis	8.07e-05	0.00567	CcSEcCtD
Diflunisal—Angioedema—Prednisolone—ankylosing spondylitis	7.98e-05	0.00561	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	7.93e-05	0.00557	CcSEcCtD
Diflunisal—Vertigo—Prednisolone—ankylosing spondylitis	7.85e-05	0.00551	CcSEcCtD
Diflunisal—Syncope—Prednisolone—ankylosing spondylitis	7.83e-05	0.0055	CcSEcCtD
Diflunisal—Loss of consciousness—Prednisolone—ankylosing spondylitis	7.68e-05	0.00539	CcSEcCtD
Diflunisal—PTGS1—tendon—ankylosing spondylitis	7.66e-05	0.0243	CbGeAlD
Diflunisal—Angioedema—Triamcinolone—ankylosing spondylitis	7.34e-05	0.00516	CcSEcCtD
Diflunisal—Angioedema—Methylprednisolone—ankylosing spondylitis	7.32e-05	0.00515	CcSEcCtD
Diflunisal—PTGS2—tendon—ankylosing spondylitis	7.32e-05	0.0232	CbGeAlD
Diflunisal—Hallucination—Prednisone—ankylosing spondylitis	7.26e-05	0.0051	CcSEcCtD
Diflunisal—Vertigo—Triamcinolone—ankylosing spondylitis	7.22e-05	0.00507	CcSEcCtD
Diflunisal—Syncope—Triamcinolone—ankylosing spondylitis	7.2e-05	0.00506	CcSEcCtD
Diflunisal—Vertigo—Methylprednisolone—ankylosing spondylitis	7.2e-05	0.00506	CcSEcCtD
Diflunisal—Syncope—Methylprednisolone—ankylosing spondylitis	7.19e-05	0.00505	CcSEcCtD
Diflunisal—Anaphylactic shock—Prednisolone—ankylosing spondylitis	7.13e-05	0.00501	CcSEcCtD
Diflunisal—Oedema—Prednisolone—ankylosing spondylitis	7.13e-05	0.00501	CcSEcCtD
Diflunisal—Dysuria—Methotrexate—ankylosing spondylitis	7.12e-05	0.005	CcSEcCtD
Diflunisal—Loss of consciousness—Triamcinolone—ankylosing spondylitis	7.06e-05	0.00496	CcSEcCtD
Diflunisal—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	7.05e-05	0.00495	CcSEcCtD
Diflunisal—Shock—Prednisolone—ankylosing spondylitis	7.01e-05	0.00493	CcSEcCtD
Diflunisal—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	6.95e-05	0.00488	CcSEcCtD
Diflunisal—Hyperhidrosis—Prednisolone—ankylosing spondylitis	6.89e-05	0.00484	CcSEcCtD
Diflunisal—Flushing—Prednisone—ankylosing spondylitis	6.77e-05	0.00475	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	6.73e-05	0.00473	CcSEcCtD
Diflunisal—Renal failure—Methotrexate—ankylosing spondylitis	6.67e-05	0.00469	CcSEcCtD
Diflunisal—Angioedema—Betamethasone—ankylosing spondylitis	6.66e-05	0.00468	CcSEcCtD
Diflunisal—Angioedema—Dexamethasone—ankylosing spondylitis	6.66e-05	0.00468	CcSEcCtD
Diflunisal—Stomatitis—Methotrexate—ankylosing spondylitis	6.62e-05	0.00465	CcSEcCtD
Diflunisal—Confusional state—Methylprednisolone—ankylosing spondylitis	6.6e-05	0.00463	CcSEcCtD
Diflunisal—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	6.56e-05	0.00461	CcSEcCtD
Diflunisal—Oedema—Triamcinolone—ankylosing spondylitis	6.56e-05	0.00461	CcSEcCtD
Diflunisal—Vertigo—Dexamethasone—ankylosing spondylitis	6.55e-05	0.0046	CcSEcCtD
Diflunisal—Vertigo—Betamethasone—ankylosing spondylitis	6.55e-05	0.0046	CcSEcCtD
Diflunisal—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	6.54e-05	0.0046	CcSEcCtD
Diflunisal—Syncope—Betamethasone—ankylosing spondylitis	6.54e-05	0.00459	CcSEcCtD
Diflunisal—Syncope—Dexamethasone—ankylosing spondylitis	6.54e-05	0.00459	CcSEcCtD
Diflunisal—Sweating—Methotrexate—ankylosing spondylitis	6.51e-05	0.00457	CcSEcCtD
Diflunisal—Haematuria—Methotrexate—ankylosing spondylitis	6.47e-05	0.00455	CcSEcCtD
Diflunisal—Shock—Triamcinolone—ankylosing spondylitis	6.45e-05	0.00453	CcSEcCtD
Diflunisal—Insomnia—Prednisolone—ankylosing spondylitis	6.45e-05	0.00453	CcSEcCtD
Diflunisal—Shock—Methylprednisolone—ankylosing spondylitis	6.44e-05	0.00452	CcSEcCtD
Diflunisal—Loss of consciousness—Dexamethasone—ankylosing spondylitis	6.41e-05	0.0045	CcSEcCtD
Diflunisal—Loss of consciousness—Betamethasone—ankylosing spondylitis	6.41e-05	0.0045	CcSEcCtD
Diflunisal—Paraesthesia—Prednisolone—ankylosing spondylitis	6.4e-05	0.0045	CcSEcCtD
Diflunisal—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	6.34e-05	0.00445	CcSEcCtD
Diflunisal—Agranulocytosis—Methotrexate—ankylosing spondylitis	6.34e-05	0.00445	CcSEcCtD
Diflunisal—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	6.32e-05	0.00444	CcSEcCtD
Diflunisal—Hepatitis—Methotrexate—ankylosing spondylitis	6.09e-05	0.00428	CcSEcCtD
Diflunisal—Vision blurred—Prednisone—ankylosing spondylitis	5.98e-05	0.0042	CcSEcCtD
Diflunisal—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	5.95e-05	0.00418	CcSEcCtD
Diflunisal—Oedema—Betamethasone—ankylosing spondylitis	5.95e-05	0.00418	CcSEcCtD
Diflunisal—Oedema—Dexamethasone—ankylosing spondylitis	5.95e-05	0.00418	CcSEcCtD
Diflunisal—Anaphylactic shock—Betamethasone—ankylosing spondylitis	5.95e-05	0.00418	CcSEcCtD
Diflunisal—Insomnia—Triamcinolone—ankylosing spondylitis	5.93e-05	0.00417	CcSEcCtD
Diflunisal—Insomnia—Methylprednisolone—ankylosing spondylitis	5.92e-05	0.00416	CcSEcCtD
Diflunisal—Paraesthesia—Triamcinolone—ankylosing spondylitis	5.89e-05	0.00414	CcSEcCtD
Diflunisal—Feeling abnormal—Prednisolone—ankylosing spondylitis	5.88e-05	0.00413	CcSEcCtD
Diflunisal—Paraesthesia—Methylprednisolone—ankylosing spondylitis	5.87e-05	0.00413	CcSEcCtD
Diflunisal—Visual impairment—Methotrexate—ankylosing spondylitis	5.87e-05	0.00413	CcSEcCtD
Diflunisal—Shock—Dexamethasone—ankylosing spondylitis	5.85e-05	0.00411	CcSEcCtD
Diflunisal—Shock—Betamethasone—ankylosing spondylitis	5.85e-05	0.00411	CcSEcCtD
Diflunisal—Dyspnoea—Triamcinolone—ankylosing spondylitis	5.85e-05	0.00411	CcSEcCtD
Diflunisal—Thrombocytopenia—Betamethasone—ankylosing spondylitis	5.83e-05	0.00409	CcSEcCtD
Diflunisal—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	5.83e-05	0.00409	CcSEcCtD
Diflunisal—Angioedema—Prednisone—ankylosing spondylitis	5.8e-05	0.00407	CcSEcCtD
Diflunisal—Dyspepsia—Triamcinolone—ankylosing spondylitis	5.77e-05	0.00405	CcSEcCtD
Diflunisal—Erythema multiforme—Methotrexate—ankylosing spondylitis	5.76e-05	0.00405	CcSEcCtD
Diflunisal—Dyspepsia—Methylprednisolone—ankylosing spondylitis	5.76e-05	0.00405	CcSEcCtD
Diflunisal—Hyperhidrosis—Betamethasone—ankylosing spondylitis	5.75e-05	0.00404	CcSEcCtD
Diflunisal—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	5.75e-05	0.00404	CcSEcCtD
Diflunisal—Vertigo—Prednisone—ankylosing spondylitis	5.7e-05	0.00401	CcSEcCtD
Diflunisal—Syncope—Prednisone—ankylosing spondylitis	5.69e-05	0.004	CcSEcCtD
Diflunisal—Tinnitus—Methotrexate—ankylosing spondylitis	5.68e-05	0.00399	CcSEcCtD
Diflunisal—Anorexia—Betamethasone—ankylosing spondylitis	5.67e-05	0.00398	CcSEcCtD
Diflunisal—Anorexia—Dexamethasone—ankylosing spondylitis	5.67e-05	0.00398	CcSEcCtD
Diflunisal—Urticaria—Prednisolone—ankylosing spondylitis	5.66e-05	0.00398	CcSEcCtD
Diflunisal—Fatigue—Triamcinolone—ankylosing spondylitis	5.65e-05	0.00397	CcSEcCtD
Diflunisal—Fatigue—Methylprednisolone—ankylosing spondylitis	5.64e-05	0.00396	CcSEcCtD
Diflunisal—Loss of consciousness—Prednisone—ankylosing spondylitis	5.58e-05	0.00392	CcSEcCtD
Diflunisal—Feeling abnormal—Triamcinolone—ankylosing spondylitis	5.4e-05	0.0038	CcSEcCtD
Diflunisal—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	5.39e-05	0.00379	CcSEcCtD
Diflunisal—Insomnia—Betamethasone—ankylosing spondylitis	5.38e-05	0.00378	CcSEcCtD
Diflunisal—Insomnia—Dexamethasone—ankylosing spondylitis	5.38e-05	0.00378	CcSEcCtD
Diflunisal—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	5.35e-05	0.00376	CcSEcCtD
Diflunisal—Paraesthesia—Dexamethasone—ankylosing spondylitis	5.34e-05	0.00375	CcSEcCtD
Diflunisal—Paraesthesia—Betamethasone—ankylosing spondylitis	5.34e-05	0.00375	CcSEcCtD
Diflunisal—Hypersensitivity—Prednisolone—ankylosing spondylitis	5.25e-05	0.00369	CcSEcCtD
Diflunisal—Dyspepsia—Betamethasone—ankylosing spondylitis	5.24e-05	0.00368	CcSEcCtD
Diflunisal—Dyspepsia—Dexamethasone—ankylosing spondylitis	5.24e-05	0.00368	CcSEcCtD
Diflunisal—Urticaria—Triamcinolone—ankylosing spondylitis	5.21e-05	0.00366	CcSEcCtD
Diflunisal—Urticaria—Methylprednisolone—ankylosing spondylitis	5.2e-05	0.00365	CcSEcCtD
Diflunisal—Body temperature increased—Triamcinolone—ankylosing spondylitis	5.18e-05	0.00364	CcSEcCtD
Diflunisal—Anaphylactic shock—Prednisone—ankylosing spondylitis	5.18e-05	0.00364	CcSEcCtD
Diflunisal—Oedema—Prednisone—ankylosing spondylitis	5.18e-05	0.00364	CcSEcCtD
Diflunisal—Decreased appetite—Dexamethasone—ankylosing spondylitis	5.17e-05	0.00363	CcSEcCtD
Diflunisal—Decreased appetite—Betamethasone—ankylosing spondylitis	5.17e-05	0.00363	CcSEcCtD
Diflunisal—Fatigue—Dexamethasone—ankylosing spondylitis	5.13e-05	0.0036	CcSEcCtD
Diflunisal—Fatigue—Betamethasone—ankylosing spondylitis	5.13e-05	0.0036	CcSEcCtD
Diflunisal—Shock—Prednisone—ankylosing spondylitis	5.1e-05	0.00358	CcSEcCtD
Diflunisal—Hyperhidrosis—Prednisone—ankylosing spondylitis	5.01e-05	0.00352	CcSEcCtD
Diflunisal—Vision blurred—Methotrexate—ankylosing spondylitis	5e-05	0.00351	CcSEcCtD
Diflunisal—Anorexia—Prednisone—ankylosing spondylitis	4.94e-05	0.00347	CcSEcCtD
Diflunisal—Feeling abnormal—Dexamethasone—ankylosing spondylitis	4.9e-05	0.00344	CcSEcCtD
Diflunisal—Feeling abnormal—Betamethasone—ankylosing spondylitis	4.9e-05	0.00344	CcSEcCtD
Diflunisal—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	4.87e-05	0.00342	CcSEcCtD
Diflunisal—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	4.87e-05	0.00342	CcSEcCtD
Diflunisal—Hypersensitivity—Triamcinolone—ankylosing spondylitis	4.83e-05	0.00339	CcSEcCtD
Diflunisal—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	4.82e-05	0.00339	CcSEcCtD
Diflunisal—Vertigo—Methotrexate—ankylosing spondylitis	4.77e-05	0.00335	CcSEcCtD
Diflunisal—Urticaria—Betamethasone—ankylosing spondylitis	4.73e-05	0.00332	CcSEcCtD
Diflunisal—Urticaria—Dexamethasone—ankylosing spondylitis	4.73e-05	0.00332	CcSEcCtD
Diflunisal—Dizziness—Prednisolone—ankylosing spondylitis	4.71e-05	0.00331	CcSEcCtD
Diflunisal—Asthenia—Triamcinolone—ankylosing spondylitis	4.7e-05	0.0033	CcSEcCtD
Diflunisal—Body temperature increased—Dexamethasone—ankylosing spondylitis	4.7e-05	0.0033	CcSEcCtD
Diflunisal—Body temperature increased—Betamethasone—ankylosing spondylitis	4.7e-05	0.0033	CcSEcCtD
Diflunisal—Asthenia—Methylprednisolone—ankylosing spondylitis	4.69e-05	0.0033	CcSEcCtD
Diflunisal—Insomnia—Prednisone—ankylosing spondylitis	4.69e-05	0.00329	CcSEcCtD
Diflunisal—Paraesthesia—Prednisone—ankylosing spondylitis	4.65e-05	0.00327	CcSEcCtD
Diflunisal—Pruritus—Triamcinolone—ankylosing spondylitis	4.64e-05	0.00326	CcSEcCtD
Diflunisal—Pruritus—Methylprednisolone—ankylosing spondylitis	4.63e-05	0.00325	CcSEcCtD
Diflunisal—Dyspepsia—Prednisone—ankylosing spondylitis	4.56e-05	0.0032	CcSEcCtD
Diflunisal—Chest pain—Methotrexate—ankylosing spondylitis	4.52e-05	0.00317	CcSEcCtD
Diflunisal—Decreased appetite—Prednisone—ankylosing spondylitis	4.5e-05	0.00316	CcSEcCtD
Diflunisal—Rash—Prednisolone—ankylosing spondylitis	4.5e-05	0.00316	CcSEcCtD
Diflunisal—Dermatitis—Prednisolone—ankylosing spondylitis	4.49e-05	0.00316	CcSEcCtD
Diflunisal—Diarrhoea—Methylprednisolone—ankylosing spondylitis	4.48e-05	0.00314	CcSEcCtD
Diflunisal—Fatigue—Prednisone—ankylosing spondylitis	4.47e-05	0.00314	CcSEcCtD
Diflunisal—Headache—Prednisolone—ankylosing spondylitis	4.47e-05	0.00314	CcSEcCtD
Diflunisal—Constipation—Prednisone—ankylosing spondylitis	4.43e-05	0.00311	CcSEcCtD
Diflunisal—Confusional state—Methotrexate—ankylosing spondylitis	4.37e-05	0.00307	CcSEcCtD
Diflunisal—Dizziness—Triamcinolone—ankylosing spondylitis	4.34e-05	0.00305	CcSEcCtD
Diflunisal—Anaphylactic shock—Methotrexate—ankylosing spondylitis	4.33e-05	0.00304	CcSEcCtD
Diflunisal—Dizziness—Methylprednisolone—ankylosing spondylitis	4.33e-05	0.00304	CcSEcCtD
Diflunisal—Feeling abnormal—Prednisone—ankylosing spondylitis	4.27e-05	0.003	CcSEcCtD
Diflunisal—Asthenia—Betamethasone—ankylosing spondylitis	4.27e-05	0.003	CcSEcCtD
Diflunisal—Asthenia—Dexamethasone—ankylosing spondylitis	4.27e-05	0.003	CcSEcCtD
Diflunisal—Thrombocytopenia—Methotrexate—ankylosing spondylitis	4.24e-05	0.00298	CcSEcCtD
Diflunisal—Gastrointestinal pain—Prednisone—ankylosing spondylitis	4.24e-05	0.00298	CcSEcCtD
Diflunisal—Nausea—Prednisolone—ankylosing spondylitis	4.24e-05	0.00297	CcSEcCtD
Diflunisal—Pruritus—Dexamethasone—ankylosing spondylitis	4.21e-05	0.00296	CcSEcCtD
Diflunisal—Pruritus—Betamethasone—ankylosing spondylitis	4.21e-05	0.00296	CcSEcCtD
Diflunisal—Hyperhidrosis—Methotrexate—ankylosing spondylitis	4.19e-05	0.00294	CcSEcCtD
Diflunisal—Vomiting—Triamcinolone—ankylosing spondylitis	4.17e-05	0.00293	CcSEcCtD
Diflunisal—Vomiting—Methylprednisolone—ankylosing spondylitis	4.16e-05	0.00292	CcSEcCtD
Diflunisal—Rash—Triamcinolone—ankylosing spondylitis	4.13e-05	0.0029	CcSEcCtD
Diflunisal—Dermatitis—Triamcinolone—ankylosing spondylitis	4.13e-05	0.0029	CcSEcCtD
Diflunisal—Anorexia—Methotrexate—ankylosing spondylitis	4.13e-05	0.0029	CcSEcCtD
Diflunisal—Rash—Methylprednisolone—ankylosing spondylitis	4.13e-05	0.0029	CcSEcCtD
Diflunisal—Dermatitis—Methylprednisolone—ankylosing spondylitis	4.12e-05	0.00289	CcSEcCtD
Diflunisal—Urticaria—Prednisone—ankylosing spondylitis	4.12e-05	0.00289	CcSEcCtD
Diflunisal—Headache—Triamcinolone—ankylosing spondylitis	4.11e-05	0.00289	CcSEcCtD
Diflunisal—Headache—Methylprednisolone—ankylosing spondylitis	4.1e-05	0.00288	CcSEcCtD
Diflunisal—Body temperature increased—Prednisone—ankylosing spondylitis	4.1e-05	0.00288	CcSEcCtD
Diflunisal—Diarrhoea—Dexamethasone—ankylosing spondylitis	4.07e-05	0.00286	CcSEcCtD
Diflunisal—Diarrhoea—Betamethasone—ankylosing spondylitis	4.07e-05	0.00286	CcSEcCtD
Diflunisal—Dizziness—Betamethasone—ankylosing spondylitis	3.93e-05	0.00276	CcSEcCtD
Diflunisal—Dizziness—Dexamethasone—ankylosing spondylitis	3.93e-05	0.00276	CcSEcCtD
Diflunisal—Insomnia—Methotrexate—ankylosing spondylitis	3.92e-05	0.00275	CcSEcCtD
Diflunisal—Nausea—Triamcinolone—ankylosing spondylitis	3.89e-05	0.00274	CcSEcCtD
Diflunisal—Paraesthesia—Methotrexate—ankylosing spondylitis	3.89e-05	0.00273	CcSEcCtD
Diflunisal—Nausea—Methylprednisolone—ankylosing spondylitis	3.89e-05	0.00273	CcSEcCtD
Diflunisal—Dyspnoea—Methotrexate—ankylosing spondylitis	3.86e-05	0.00271	CcSEcCtD
Diflunisal—Somnolence—Methotrexate—ankylosing spondylitis	3.85e-05	0.0027	CcSEcCtD
Diflunisal—Hypersensitivity—Prednisone—ankylosing spondylitis	3.82e-05	0.00268	CcSEcCtD
Diflunisal—Dyspepsia—Methotrexate—ankylosing spondylitis	3.81e-05	0.00268	CcSEcCtD
Diflunisal—Vomiting—Dexamethasone—ankylosing spondylitis	3.78e-05	0.00266	CcSEcCtD
Diflunisal—Vomiting—Betamethasone—ankylosing spondylitis	3.78e-05	0.00266	CcSEcCtD
Diflunisal—Decreased appetite—Methotrexate—ankylosing spondylitis	3.76e-05	0.00264	CcSEcCtD
Diflunisal—Rash—Dexamethasone—ankylosing spondylitis	3.75e-05	0.00264	CcSEcCtD
Diflunisal—Rash—Betamethasone—ankylosing spondylitis	3.75e-05	0.00264	CcSEcCtD
Diflunisal—Dermatitis—Betamethasone—ankylosing spondylitis	3.75e-05	0.00263	CcSEcCtD
Diflunisal—Dermatitis—Dexamethasone—ankylosing spondylitis	3.75e-05	0.00263	CcSEcCtD
Diflunisal—Fatigue—Methotrexate—ankylosing spondylitis	3.73e-05	0.00262	CcSEcCtD
Diflunisal—Headache—Dexamethasone—ankylosing spondylitis	3.73e-05	0.00262	CcSEcCtD
Diflunisal—Headache—Betamethasone—ankylosing spondylitis	3.73e-05	0.00262	CcSEcCtD
Diflunisal—Asthenia—Prednisone—ankylosing spondylitis	3.72e-05	0.00261	CcSEcCtD
Diflunisal—Pruritus—Prednisone—ankylosing spondylitis	3.67e-05	0.00257	CcSEcCtD
Diflunisal—Feeling abnormal—Methotrexate—ankylosing spondylitis	3.57e-05	0.00251	CcSEcCtD
Diflunisal—Diarrhoea—Prednisone—ankylosing spondylitis	3.55e-05	0.00249	CcSEcCtD
Diflunisal—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	3.54e-05	0.00249	CcSEcCtD
Diflunisal—Nausea—Betamethasone—ankylosing spondylitis	3.53e-05	0.00248	CcSEcCtD
Diflunisal—Nausea—Dexamethasone—ankylosing spondylitis	3.53e-05	0.00248	CcSEcCtD
Diflunisal—Urticaria—Methotrexate—ankylosing spondylitis	3.44e-05	0.00242	CcSEcCtD
Diflunisal—Dizziness—Prednisone—ankylosing spondylitis	3.43e-05	0.00241	CcSEcCtD
Diflunisal—Body temperature increased—Methotrexate—ankylosing spondylitis	3.42e-05	0.0024	CcSEcCtD
Diflunisal—Vomiting—Prednisone—ankylosing spondylitis	3.29e-05	0.00231	CcSEcCtD
Diflunisal—Rash—Prednisone—ankylosing spondylitis	3.27e-05	0.00229	CcSEcCtD
Diflunisal—Dermatitis—Prednisone—ankylosing spondylitis	3.26e-05	0.00229	CcSEcCtD
Diflunisal—Headache—Prednisone—ankylosing spondylitis	3.25e-05	0.00228	CcSEcCtD
Diflunisal—Hypersensitivity—Methotrexate—ankylosing spondylitis	3.19e-05	0.00224	CcSEcCtD
Diflunisal—Asthenia—Methotrexate—ankylosing spondylitis	3.11e-05	0.00218	CcSEcCtD
Diflunisal—Nausea—Prednisone—ankylosing spondylitis	3.08e-05	0.00216	CcSEcCtD
Diflunisal—Pruritus—Methotrexate—ankylosing spondylitis	3.06e-05	0.00215	CcSEcCtD
Diflunisal—Diarrhoea—Methotrexate—ankylosing spondylitis	2.96e-05	0.00208	CcSEcCtD
Diflunisal—Dizziness—Methotrexate—ankylosing spondylitis	2.86e-05	0.00201	CcSEcCtD
Diflunisal—Vomiting—Methotrexate—ankylosing spondylitis	2.75e-05	0.00193	CcSEcCtD
Diflunisal—Rash—Methotrexate—ankylosing spondylitis	2.73e-05	0.00192	CcSEcCtD
Diflunisal—Dermatitis—Methotrexate—ankylosing spondylitis	2.73e-05	0.00192	CcSEcCtD
Diflunisal—Headache—Methotrexate—ankylosing spondylitis	2.71e-05	0.00191	CcSEcCtD
Diflunisal—Nausea—Methotrexate—ankylosing spondylitis	2.57e-05	0.00181	CcSEcCtD
